Discover protective tips to lower lung cancer risk even with a smoking history. Proven approaches for current and former ...

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

A mum of two from Hampton Magna is hoping to set a new world record when she runs the London Marathon in costume, despite ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

The new chief medical officer of the Pulmonary Fibrosis Foundation speaks about patients in rural areas, research ...

A program that supplies schools with stock inhalers was well received by school health personnel/nurses in Illinois, according to two posters presented here.Both posters were presented at the 2025 ...

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...

Receiving admilparant, an oral lysophosphatidic acid receptor 1 antagonist, for 26 weeks lowered percent-predicted FVC ...

Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...

A lung cancer diagnosis can be confirmed with ... While most targeted therapies are used to treat adenocarcinomas, these medications are both appropriate for the treatment of squamous cell carcinomas.

Beyond nicotine-related conditions, Pneuma’s inhaled therapeutics have broad potential in treating other lung diseases. With its fully digital technology, the company aims to improve treatment ...